Endocrinology - Obesity and lipids

Obesity is a serious health problem that is increasing in society. Overweight and obesity are important risk factors for heart disease. Many risk factors for heart disease have been suggested in overweight and obese people, including dyslipidemia and irritability. Adiponectin, a hormone released by adipose tissue, has both weight loss and weight loss properties. Numerous studies have explained the relationship between adiponectin and obesity in different populations. LDL cholesterol plays an important role in this "diabetic dyslipidemia" and is considered to be severely atherogenic, a greater cause than a clear indication of increased risk. A variation known as VLDL, low-density lipoprotein, appears to be particularly dangerous—but it appears that increasing HDL, high-density lipoprotein cholesterol, can control its harmful activity or no decrease associated with LDL counts.

  • Elevated Cholesterol
  • Elevated Triglycerides
  • Elevated Triglycerides
  • Obesity/Metabolic Syndrome

Related Conference of Endocrinology - Obesity and lipids

November 22-23, 2024

20th World Congress on Endocrinology & Diabetes

Amsterdam, Netherlands
November 27-28, 2024

14th World Congress on Endocrinology and Diabetes

Paris, France
February 24-25, 2025

34th European Diabetes Congress

London, UK
March 10-11, 2025

4th Global Summit on Physiology and Metabolism of Thyroid

Singapore City, Singapore
March 17-18, 2025

5th European Endocrinology and Diabetes Congress

Paris, France
April 10-11, 2025

4th International Summit on Hormonal Disorders

Dubai, UAE
April 10-11, 2025

5th World Congress on Endocrine and Diabetes

Dubai, UAE
May 19-20, 2025

6th World Summit on Diabetes

Rome, Italy
June 04-05, 2025

4th World Congress on Diabetes and Pediatric Endocrinology

Edinburgh, Scotland

Endocrinology - Obesity and lipids Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in